The use of alternative sample matrices may be an advantageous perspective when the laboratory falls short of serum or lithium-heparin plasma for performing clinical chemistry and/or immunochemistry testing. This study was aimed at exploring whether some tests may be performed in citrate plasma as an alternative to lithium-heparin plasma.
Paired lithium-heparin and citrate plasma samples collected from 55 inpatients were analyzed on Roche Cobas 8000 for 28 different clinical chemistry and immunochemistry parameters. Data obtained in citrate plasma were adjusted for either the dilution factor or using an equation corresponding to the linear regression calculated by comparing unadjusted lithium-heparin and citrate plasma values.
Except for magnesium (+17%) and sodium (+11%), unadjusted values of all remaining analytes were significantly lower in citrate than in lithium-heparin plasma, with bias ranging between −6.4% and −25.9%. The correlation between lithium-heparin and citrate plasma values was generally excellent (i.e. >0.90). The adjustment of citrate plasma values for the dilution factor (i.e. 1.1) was only effective in harmonizing the results of albumin and lipase, whilst the concentration of all other analytes remained significantly different between the two sample matrices. The adjustment of plasma citrate values using corrective formulas was instead effective in harmonizing all parameters, with no results remaining statistically different between the two sample matrices.
Citrate plasma may be used in exceptional circumstances for clinical chemistry and immunochemistry testing as a replacement for lithium-heparin plasma, provided that citrate plasma values are adjusted by using validated corrective equations.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
2. Lippi G, Giavarina D, Gelati M, Salvagno GL. Reference range of hemolysis index in serum and lithium-heparin plasma measured with two analytical platforms in a population of unselected outpatients. Clin Chim Acta 2014;429:143–6.10.1016/j.cca.2013.12.010Search in Google Scholar PubMed
3. Lippi G, Lampus S, Danese E, Montagnana M, Salvagno GL. Values and stability of serum (or plasma) indices in uncentrifuged serum and lithium-heparin plasma. Diagnosis (Berl) 2019;6:45–7.10.1515/dx-2018-0021Search in Google Scholar PubMed
4. Plebani M, Banfi G, Bernardini S, Bondanini F, Conti L, Dorizzi R, et al. Serum or plasma? An old question awaiting for new answers. Biochim Clin, 2019; in press. DOI: 10.19186/BC_2018.069.Search in Google Scholar
5. Lippi G, Giavarina D. A survey on sample matrix and preanalytical management in clinical laboratories. Biochim Clin 2017;41:142–7.Search in Google Scholar
6. Lippi G. The irreplaceable value of laboratory diagnostics: four recent tests that have revolutionized clinical practice. EJIFCC 2019;30:7–13.Search in Google Scholar
7. Cornes M, van Dongen-Lases E, Grankvist K, Ibarz M, Kristensen G, Lippi G, et al. Order of blood draw: opinion paper by the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE). Clin Chem Lab Med 2017;55:27–31.10.1515/cclm-2016-0426Search in Google Scholar PubMed
8. Banfi G, Salvagno GL, Lippi G. The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes. Clin Chem Lab Med 2007;45:565–76.10.1515/CCLM.2007.110Search in Google Scholar PubMed
11. Lippi G, Salvagno GL, Brocco G, Gelati M, Danese E, Favaloro EJ. Impact of experimental hypercalcemia on routine haemostasis testing. PLoS One 2017;12:e0175094.10.1371/journal.pone.0175094Search in Google Scholar PubMed PubMed Central
12. Lippi G, Salvagno GL, Adcock DM, Gelati M, Guidi GC,Favaloro EJ. Right or wrong sample received for coagulation testing? Tentative algorithms for detection of an incorrect type of sample. Int J Lab Hematol 2010;32:132–8.10.1111/j.1751-553X.2009.01142.xSearch in Google Scholar PubMed
13. Smith JC Jr, Lewis S, Holbrook J, Seidel K, Rose A. Effect of heparin and citrate on measured concentrations of various analytes in plasma. Clin Chem 1987;33:814–6.10.1093/clinchem/33.6.814Search in Google Scholar
14. Cerón JJ, Martínez-Subiela S, Hennemann C, Tecles F. The effects of different anticoagulants on routine canine plasma biochemistry. Vet J 2004;167:294–301.10.1016/j.tvjl.2003.09.009Search in Google Scholar PubMed
15. Mohri M, Rezapoor H. Effects of heparin, citrate, and EDTA on plasma biochemistry of sheep: comparison with serum. Res Vet Sci 2009;86:111–4.10.1016/j.rvsc.2008.05.010Search in Google Scholar PubMed
16. van den Besselaar AM, van Zanten AP, Brantjes HM, Elisen MG, van der Meer FJ, Poland DC, et al. Comparative study of blood collection tubes and thromboplastin reagents for correction of INR discrepancies: a proposal for maximum allowable magnesium contamination in sodium citrate anticoagulant solutions. Am J Clin Pathol 2012;138:248–54.10.1309/AJCPGSB5YPJRREEVSearch in Google Scholar PubMed
17. Lima-Oliveira G, Lippi G, Salvagno GL, Montagnana M, Picheth G, Guidi GC. Preanalytical management: serum vacuum tubes validation for routine clinical chemistry. Biochem Med (Zagreb) 2012;22:180–6.10.11613/BM.2012.021Search in Google Scholar PubMed PubMed Central
©2019 Walter de Gruyter GmbH, Berlin/Boston